HighVista Strategies’s Biomea Fusion BMEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-37,600
Closed -$825K 141
2023
Q2
$825K Buy
+37,600
New +$1.18M 0.38% 64
2023
Q1
Sell
-144,727
Closed -$1.22M 109
2022
Q4
$1.22M Hold
144,727
0.72% 35
2022
Q3
$1.42M Hold
144,727
0.81% 34
2022
Q2
$1.73M Buy
144,727
+31,809
+28% +$186K 1.05% 31
2022
Q1
$504K Buy
+112,918
New +$732K 0.32% 72

Other funds holding BMEA

HighVista Strategies's BMEA Position: Q3 2023 in Review

HighVista Strategies sold out of Biomea Fusion (BMEA) in Q3 2023, closing a stake of 37,600 shares — an estimated $825K sold.

HighVista Strategies first reported a position in BMEA in Q1 2022 and held it in 5 quarters. The position peaked at $1.73M in Q2 2022. 85 funds tracked by Wall St. Rank hold BMEA as of Q3 2023.

  • HighVista Strategies reported no remaining Biomea Fusion position as of Q3 2023 after selling out during the quarter.
  • HighVista Strategies sold 37,600 Biomea Fusion shares in Q3 2023, an estimated $825K.
  • HighVista Strategies first reported a position in Biomea Fusion in Q1 2022 and held it in 5 quarters.
  • HighVista Strategies's Biomea Fusion position peaked at $1.73M in Q2 2022.
  • 85 funds tracked by Wall St. Rank held Biomea Fusion as of Q3 2023.

Based on HighVista Strategies's 13F filing for Q3 2023, filed 14 Nov 2023.